These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two aid the principle of targeting ACKR3 as a unique technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Ailments. Importantly, these receptors were https://benjamina158srn9.gynoblog.com/profile